Jazz Pharmaceuticals Plc Stock Today
| JAZZ Stock | USD 109.27 2.17 2.03% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Jazz Pharmaceuticals is trading at 109.27 as of the 19th of April 2024; that is 2.03 percent increase since the beginning of the trading day. The stock's open price was 107.1. Jazz Pharmaceuticals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Jazz Pharmaceuticals PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2022 and ending today, the 19th of April 2024. Click here to learn more.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland. The company has 62.35 M outstanding shares of which 3.26 M shares are currently shorted by private and institutional investors with about 3.98 trading days to cover. More on Jazz Pharmaceuticals PLC
Moving against Jazz Stock
| 0.67 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
| 0.66 | DOMH | Dominari Holdings | PairCorr |
| 0.5 | DSGN | Design Therapeutics Downward Rally | PairCorr |
| 0.46 | VIRI | Virios Therapeutics Llc Financial Report 9th of May 2024 | PairCorr |
| 0.41 | VANI | Vivani Medical | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 8th of May 2024
Jazz Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Jazz Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Jazz Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Bruce Cozadd |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, ARCA Pharmaceutical, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength Based on the key indicators related to Jazz Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Jazz Pharmaceuticals PLC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Jazz Pharmaceuticals PLC is based on its profitability, leverage, liquidity, source of funds, and operating efficiency. | |
Jazz Pharmaceuticals PLC (JAZZ) is traded on NASDAQ Exchange in USA. It is located in Waterloo Exchange, Dublin, Ireland, D04 E5W7 and employs 2,800 people. Jazz Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.79 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jazz Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Jazz Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Jazz Pharmaceuticals PLC conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 62.35 M outstanding shares of which 3.26 M shares are currently shorted by private and institutional investors with about 3.98 trading days to cover.
Jazz Pharmaceuticals PLC currently holds about 899.36 M in cash with 1.09 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.28.
Check Jazz Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationJazz Pharmaceuticals PLC has a total of 62.35 Million outstanding shares. The majority of Jazz Pharmaceuticals PLC outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Jazz Pharmaceuticals to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Jazz Pharmaceuticals PLC. Please pay attention to any change in the institutional holdings of Jazz Pharmaceuticals PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Jazz Ownership Details
Jazz Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Jazz Pharmaceuticals jumping above the current price in 90 days from now is about 97.0%. The Jazz Pharmaceuticals PLC probability density function shows the probability of Jazz Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Jazz Pharmaceuticals has a beta of 0.0941. This indicates as returns on the market go up, Jazz Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Jazz Pharmaceuticals PLC will be expected to be much smaller as well. Additionally, jazz Pharmaceuticals PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Jazz Pharmaceuticals to move above the current price in 90 days from now is about 97.0 (This Jazz Pharmaceuticals PLC probability density function shows the probability of Jazz Stock to fall within a particular range of prices over 90 days) .
Jazz Pharmaceuticals PLC Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Jazz Pharmaceuticals market risk premium is the additional return an investor will receive from holding Jazz Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Jazz Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Jazz Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Jazz Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (1.49) |
Jazz Stock Against Markets
Picking the right benchmark for Jazz Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Jazz Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Jazz Pharmaceuticals is critical whether you are bullish or bearish towards Jazz Pharmaceuticals PLC at a given time. Please also check how Jazz Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Jazz Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Jazz Pharmaceuticals Corporate Directors
Jazz Pharmaceuticals corporate directors refer to members of a Jazz Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Jazz Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Jazz Pharmaceuticals' board members must vote for the resolution. The Jazz Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Diane Schrick | Senior Director, Investor Relations | Profile | |
| Rick Winningham | Independent Director | Profile | |
| Peter Gray | Independent Director | Profile | |
| Seamus Mulligan | Director | Profile |
How to buy Jazz Stock?
Before investing in Jazz Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Jazz Pharmaceuticals. To buy Jazz Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Jazz Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Jazz Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Jazz Pharmaceuticals PLC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Jazz Pharmaceuticals PLC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Jazz Pharmaceuticals PLC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Jazz Stock please use our How to Invest in Jazz Pharmaceuticals guide.
Already Invested in Jazz Pharmaceuticals PLC?
The danger of trading Jazz Pharmaceuticals PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Jazz Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Jazz Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Jazz Pharmaceuticals PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Jazz Pharmaceuticals PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Jazz Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jazz Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Jazz Pharmaceuticals Plc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Jazz Pharmaceuticals PLC information on this page should be used as a complementary analysis to other Jazz Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Jazz Stock analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets |
Is Jazz Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jazz Pharmaceuticals. If investors know Jazz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jazz Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Jazz Pharmaceuticals PLC is measured differently than its book value, which is the value of Jazz that is recorded on the company's balance sheet. Investors also form their own opinion of Jazz Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Jazz Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jazz Pharmaceuticals' market value can be influenced by many factors that don't directly affect Jazz Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jazz Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jazz Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jazz Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.